Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 2
2009 1
2013 1
2014 5
2015 2
2016 1
2017 1
2018 2
2019 3
2021 1
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk.
Fadini GP, Longato E, Morieri ML, Del Prato S, Avogaro A, Solini A; DARWIN-Renal Study Investigators. Fadini GP, et al. Lancet Reg Health Eur. 2024 Feb 1;38:100847. doi: 10.1016/j.lanepe.2024.100847. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38328413 Free PMC article.
Design and challenges of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy (RENAL) Trial: high-dose versus standard-dose hemofiltration in acute renal failure.
RENAL Study Investigators; Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Goldsmith D, Myburgh J, Norton R, Scheinkestel C. RENAL Study Investigators, et al. Blood Purif. 2008;26(5):407-16. doi: 10.1159/000148400. Blood Purif. 2008. PMID: 18856012 Free article. Review.
Hyperoncotic Albumin Solution in Continuous Renal Replacement Therapy Patients.
O'Brien Z, Finnis M, Gallagher M, Bellomo R; RENAL Study Investigators and the Australian and New Zealand Intensive Care Clinical Trials Group. O'Brien Z, et al. Blood Purif. 2022;51(7):590-599. doi: 10.1159/000517957. Epub 2021 Aug 12. Blood Purif. 2022. PMID: 34515056 Free PMC article.
Health-related quality of life in survivors of acute kidney injury: The Prolonged Outcomes Study of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy study outcomes.
Wang AY, Bellomo R, Cass A, Finfer S, Gattas D, Myburgh J, Chadban S, Hirakawa Y, Ninomiya T, Li Q, Lo S, Barzi F, Sukkar L, Jardine M, Gallagher MP; POST-RENAL Study Investigators and the ANZICS Clinical Trials Group. Wang AY, et al. Nephrology (Carlton). 2015 Jul;20(7):492-8. doi: 10.1111/nep.12488. Nephrology (Carlton). 2015. PMID: 25891297 Clinical Trial.
Calorie intake and patient outcomes in severe acute kidney injury: findings from The Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy (RENAL) study trial.
Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lee J, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C; RENAL Study Investigators; Su S. Bellomo R, et al. Crit Care. 2014 Mar 14;18(2):R45. doi: 10.1186/cc13767. Crit Care. 2014. PMID: 24629036 Free PMC article. Clinical Trial.
19 results